A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting

American Heart Journal

Volumn 139, Issue 1 I, 2000, Pages 35-43

  Kurz, David J ^a   Naegeli, Barbara ^a   Bertel, Osmund ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NITRATE; STATIN; TROPONIN I;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY STENT; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MICROVASCULATURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033976961     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90306-5     Document Type: Article

References (24)

1. Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994;127:13-20.
2. Karim MA, Shinn M, Oskarsson H, et al. Significance of troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;76:521-3.
3. La Vecchia L, Bedogni F, Finocchi G, et al. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis 1996;7:535-40.
4. Yusuf S, Collins R, MacMahon S, et al. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1988;331:1088-92.
5. Bussmann WD, Passek D, Seidel W, et al. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 1981;63:615-22.
6. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications. Circulation 1988;78:906-19.
7. DeMaria AN, Vismara LA, Auditore K, et al. Effects of nitroglycerin on left ventricular cavity size and cardiac performance determined by ultrasound in man. Am J Med 1974;57:754-60.
8. Greenberg H, Dwyer EM, Jameson AG, et al. Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. Am J Cardiol 1975;36:426-32.
9. Horwitz LD, Godin R, Taylor WJ, et al. Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J Clin Invest 1971;50:1578-84.
10. Fallen EL, Nahmias C, Scheffel A, et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995;91:1381-8.
11. Goldstein RE, Stinson EB, Scherer JL, et al. Intraoperative coronary collateral function in patients with coronary occlusive disease: nitroglycerin responsiveness and angiographic correlations. Circulation 1974;49:298-308.
12. Piek JJ, van Liebergen PA, Koch KT, et al. Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model. Circulation 1997;96:106-15.
13. Loscalzo J. Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol 1992;70:18B-22B.
14. Fallen EL, Cairns JA, Stolberg HO, et al. Relief of coronary artery spasm by nitroglycerin: time dependent variability in drug action. Cathet Cardiovasc Diagn 1978;4:237-47.
15. Gruppo Italiano per Io Studio della Sopravvivenza nell'Infarto Miocardico: GISSI-3. Effects of lisonopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
16. Fourth International Study of Infarct Survival (ISIS-4) Collaborative Group. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
17. Jugdutt BI, Schwarz-Michorowski BL, Tymchak WJ, et al. Prompt improvement of left ventricular function and preservation of topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction. Cardiology 1997;88:170-9.
18. Antmann EA, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
19. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
20. Abdelmeguid AE, Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 1996;131:1097-105.
21. Rupprecht HJ, Terres W, Ozbeck C, et al. Recombinant hirudin (HBW 023) prevents troponin-T release after coronary angioplasty in patients with unstable angina. J Am Coll Cardiol 1995;26:1637-42.
22. Abdelmeguid AE, Topol EJ. The myth of myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation 1996;94:3369-75.
23. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
24. IMPACT-II investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II: Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet 1997;349:1422-8.